Sheridan backs TarryTown ExpoCare in $160 mln deal

The deal for the IDD-focused pharmacy concludes a GuideCap Partners-run sales process.

7 January 2020•2 mins read
healthcare, private equity, pharmacy, Sheridan Capital Partners, TarryTown
LinkedInXEmail
LinkedInXEmail

Related articles